Research Associate I/II

Flagship Pioneering

Flagship Pioneering

501-1,000 employees

Originates biotech ventures for health and sustainability

Venture Capital

Entry, Junior, Mid

Cambridge, MA, USA

Required Skills
  • BS/MS in Biochemistry, Biomedical engineering, or related field
  • 0-2 years of academic or biotech/pharma laboratory experience is desirable
  • Experience with recombinant protein expression and purification using mammalian cell lines is preferred
  • Experience with FPLC systems and with affinity, IEX and SEC protein purification methods is preferred
  • Experience with general in vitro cell culture techniques is preferred
  • Strong organizational and communication skills along with excellent attention to details is a must
  • Enjoys working in a collaborative, fast-paced and quickly changing environment
  • Express and purify recombinant proteins from mammalian cultures
  • Routinely perform molecular biology techniques such as PCR, plasmid DNA preparation and bacterial transformation
  • Execute small- and large-scale protein purifications using immobilized metal affinity, ion-exchange, and size exclusion chromatography
  • Characterize recombinant proteins using SDS-PAGE, WB, protein quantitation, HPLC, ELISA and other biochemical/biophysical assays such as BLI and SPR to determine protein purity and function
  • Capture primary data and document work as required in Electronic Laboratory Notebook (ELN), maintaining up to date records
  • Present data routinely to the Protein Sciences group and other Ampersand teams

Flagship Pioneering stands out as a leader in the biotechnology industry, having originated and nurtured over 100 scientific ventures, including high-profile companies like Moderna and Indigo Agriculture. The company's culture is rooted in developing transformative products for human health and sustainability, as evidenced by their creation of platform companies like Generate Biomedicines and Tessera Therapeutics. Their competitive edge lies in their ability to explore new frontiers in genetics, as demonstrated by their recent unveiling of Quotient Therapeutics, a venture aimed at creating transformative medicines.

Company Stage


Total Funding



Cambridge, Massachusetts



Growth & Insights

6 month growth


1 year growth


2 year growth